Kevin D. Pile

2.1k total citations
48 papers, 1.4k citations indexed

About

Kevin D. Pile is a scholar working on Rheumatology, Surgery and Immunology. According to data from OpenAlex, Kevin D. Pile has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Rheumatology, 10 papers in Surgery and 9 papers in Immunology. Recurrent topics in Kevin D. Pile's work include Rheumatoid Arthritis Research and Therapies (18 papers), Spondyloarthritis Studies and Treatments (11 papers) and Systemic Lupus Erythematosus Research (9 papers). Kevin D. Pile is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (18 papers), Spondyloarthritis Studies and Treatments (11 papers) and Systemic Lupus Erythematosus Research (9 papers). Kevin D. Pile collaborates with scholars based in Australia, United Kingdom and United States. Kevin D. Pile's co-authors include Leighton Barnden, Richard Kwiatek, Andrei Călin, L G Kennedy, Matthew A. Brown, Christopher C. Rowe, Richard Jarrett, Raymond Tedman, Kathryn Gibson and Richard O. Day and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Immunology and Clinical Pharmacokinetics.

In The Last Decade

Kevin D. Pile

45 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin D. Pile Australia 23 607 352 188 185 181 48 1.4k
S Bombardieri Italy 19 741 1.2× 311 0.9× 108 0.6× 173 0.9× 164 0.9× 33 1.8k
Özlem Baysal Türkiye 21 424 0.7× 155 0.4× 119 0.6× 128 0.7× 285 1.6× 44 1.3k
Athan Baillet France 20 897 1.5× 395 1.1× 419 2.2× 102 0.6× 127 0.7× 83 1.6k
Moshe Tishler Israel 24 566 0.9× 260 0.7× 213 1.1× 158 0.9× 173 1.0× 83 1.7k
Inge Christoffer Olsen Norway 28 1.4k 2.3× 417 1.2× 384 2.0× 106 0.6× 193 1.1× 96 2.4k
Humeira Badsha Singapore 22 1.0k 1.7× 588 1.7× 176 0.9× 70 0.4× 159 0.9× 42 1.7k
Alexander Fraser Ireland 19 1.1k 1.8× 329 0.9× 587 3.1× 77 0.4× 127 0.7× 63 1.6k
Gyula Poór Hungary 26 564 0.9× 343 1.0× 137 0.7× 59 0.3× 455 2.5× 97 2.2k
Manoel Barros Bértolo Brazil 25 992 1.6× 349 1.0× 405 2.2× 69 0.4× 145 0.8× 109 1.8k
Pascal Hilliquin France 22 810 1.3× 167 0.5× 101 0.5× 66 0.4× 380 2.1× 82 1.6k

Countries citing papers authored by Kevin D. Pile

Since Specialization
Citations

This map shows the geographic impact of Kevin D. Pile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin D. Pile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin D. Pile more than expected).

Fields of papers citing papers by Kevin D. Pile

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin D. Pile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin D. Pile. The network helps show where Kevin D. Pile may publish in the future.

Co-authorship network of co-authors of Kevin D. Pile

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin D. Pile. A scholar is included among the top collaborators of Kevin D. Pile based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin D. Pile. Kevin D. Pile is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abuhelwa, Ahmad Y., David Foster, Janna K. Duong, et al.. (2022). Population pharmacokinetic modelling of febuxostat in healthy subjects and people with gout. British Journal of Clinical Pharmacology. 88(12). 5359–5368. 5 indexed citations
2.
Graham, Garry G., Sophie L. Stocker, Zhixin Liu, et al.. (2020). A pharmacokinetic‐pharmacodynamic study of a single dose of febuxostat in healthy subjects. British Journal of Clinical Pharmacology. 86(12). 2486–2496. 8 indexed citations
3.
Williams, Kenneth M., Garry G. Graham, Ross Norris, et al.. (2019). Determination of febuxostat in human plasma by high performance liquid chromatography (HPLC) with fluorescence-detection. Journal of Chromatography B. 1126-1127. 121764–121764. 14 indexed citations
4.
El‐Haddad, Carlos, et al.. (2019). Systematic review of depression and anxiety in psoriatic arthritis. International Journal of Rheumatic Diseases. 22(6). 967–973. 37 indexed citations
5.
Graham, Garry G., et al.. (2016). Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat. Clinical Pharmacokinetics. 56(5). 459–475. 41 indexed citations
6.
Mandal, Santosh K., Kevin D. Pile, Raju Titus Chacko, & Debashish Danda. (2014). Malignancy and autoimmunity: causally or casually related?. International Journal of Rheumatic Diseases. 17(6). 601–605. 7 indexed citations
7.
Saleh, Jamal Al, Gerd‐Rüdiger Burmester, Maurizio Cutolo, et al.. (2014). The global challenges and opportunities in the practice of rheumatology: White paper by the World Forum on Rheumatic and Musculoskeletal Diseases. Clinical Rheumatology. 34(5). 819–829. 143 indexed citations
8.
Keen, Helen, Kevin D. Pile, & Catherine Hill. (2005). The prevalence of underpowered randomized clinical trials in rheumatology.. PubMed. 32(11). 2083–8. 29 indexed citations
9.
Smith, Brian J., Laura L Laslett, Kevin D. Pile, et al.. (2004). Randomized controlled trial of alendronate in airways disease and low bone mineral density. Chronic Respiratory Disease. 1(3). 131–137. 31 indexed citations
10.
Lester, Sue, Debashish Danda, Dana Cavill, et al.. (2003). Humoral immunity to Ro52 is not associated with the Ro52 9571 C/T polymorphism in Australian patients with primary Sjögren's syndrome. Arthritis & Rheumatism. 48(11). 3293–3294. 2 indexed citations
11.
Walker, Jenny, Michael Ahern, Malcolm Smith, et al.. (2003). Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment. Internal Medicine Journal. 33(5-6). 216–220. 55 indexed citations
12.
Wellby, M.L., et al.. (2001). Serum interleukin-6 and thyroid hormones in rheumatoid arthritis. Metabolism. 50(4). 463–467. 15 indexed citations
13.
Barnden, Leighton, Richard Kwiatek, Brian F. Hutton, et al.. (2000). Validation of fully automatic brain SPET to MR co-registration. European Journal of Nuclear Medicine and Molecular Imaging. 27(2). 147–154. 32 indexed citations
14.
Beltrame, John F., et al.. (1999). Evaluation of antibodies to β2‐glycoprotein 1 in the causation of coronary atherosclerosis as part of the antiphospholipid syndrome. Australian and New Zealand Journal of Medicine. 29(6). 789–793. 9 indexed citations
15.
Bond, Colin W., Kevin D. Pile, Julian McNeil, et al.. (1998). South australian scleroderma register: Analysis of deceased patients. Pathology. 30(4). 386–390. 15 indexed citations
16.
Gendi, Nagui, et al.. (1997). Synovectomy of the elbow and radial head excision in rheumatoid arthritis: Predictive factors and long-term outcome. Journal of Bone and Joint Surgery - British Volume. 79(6). 918–923. 35 indexed citations
17.
Hall, Frances, Daniel E. Weeks, J. Camilleri, et al.. (1996). Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis. QJM. 89(11). 821–830. 64 indexed citations
18.
Hill, Catherine, Kevin D. Pile, Doug Henderson, & B. W. Kirkham. (1995). NEUROLOGICAL SIDE EFFECTS IN TWO PATIENTS RECEIVING GOLD INJECTIONS FOR RHEUMATOID ARTHRITIS. Lara D. Veeken. 34(10). 989–990. 3 indexed citations
19.
Pile, Kevin D., B. P. Wordsworth, Jerry S. Lanchbury, William Ollier, & J I Bell. (1992). HLA-DR HETEROZYGOSITY CONTRIBUTES SUSCEPTIBILITY TO SEVERE RHEUMATOID-ARTHRITIS. Lara D. Veeken. 31. 209–209. 1 indexed citations
20.
Pile, Kevin D., Nagui Gendi, & A G Mowat. (1992). Scleroderma with bilateral synovial fistulae.. PubMed. 19(7). 1150–2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S Bombardieri Breakdown of academic impact, for papers by Özlem Baysal Breakdown of academic impact, for papers by Athan Baillet Breakdown of academic impact, for papers by Moshe Tishler Breakdown of academic impact, for papers by Inge Christoffer Olsen Breakdown of academic impact, for papers by Humeira Badsha Breakdown of academic impact, for papers by Alexander Fraser Breakdown of academic impact, for papers by Gyula Poór Breakdown of academic impact, for papers by Manoel Barros Bértolo Breakdown of academic impact, for papers by Pascal Hilliquin
Rankless by CCL
2026